Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 30, 2018
Patent Application Number
14883752
Date Filed
October 15, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein is a novel recombinant virus vector derived from the attenuated vaccinia virus strain KVAC103. The recombinant virus vector is obtained by inserting an exogenous gene into the KVAC103 and may be used as a safe vaccine delivery vehicle in mammals. Particularly, recombinant viruses obtained by rescuing some of the genes deleted from the parent virus have an enhanced ability to proliferate in cells being cultured, and thus are easily produced. In addition, the recombinant viruses express an increased level of an exogenous antigen, and thus has enhanced immunogenic efficacy. Such recombinant virus vectors may be used in vaccines for preventing diseases, therapeutic vaccines, and molecular biological studies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
